Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R. K., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,109 · see citing works

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., Erfan, J., Zabolotnyy, D., Kienzer, H.-R., Cupissol, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802656 · Cited by 3,726 · see citing works

The role of radiotherapy in cancer treatment

Delaney, G. P., Jacob, S., Featherstone, C. J., & Barton, M. B. (2005) · Cancer · doi:10.1002/cncr.21324 · Cited by 1,743 · see citing works

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Kwon, E. D., Drake, C. G., Scher, H. I., Fizazi, K., Bossi, A., van den Eertwegh, A. J. M., Krainer, M., Houede, N., Santos, R., Mahammedi, H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70189-5 · Cited by 1,511 · see citing works

Using immunotherapy to boost the abscopal effect

Ngwa, W., Irabor, O. C., Schoenfeld, J. D., Hesser, J., Demaria, S., & Formenti, S. C. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2018.6 · Cited by 1,260 · see citing works

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

Shaverdian, N., Lisberg, A. E., Bornazyan, K., Veruttipong, D., Goldman, J. W., Formenti, S. C., Garon, E. B., & Lee, P. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30380-7 · Cited by 1,091 · see citing works

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer

Weickhardt, A. J., Scheier, B., Burke, J. M., Gan, G., Lu, X., Bunn, P. A., Aisner, D. L., Gaspar, L. E., Kavanagh, B. D., Doebele, R. C., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745948 · Cited by 684 · see citing works

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023

Kelly, K., Chansky, K., Gaspar, L. E., Albain, K. S., Jett, J., Ung, Y. C., Lau, D. H. M., Crowley, J. J., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4824 · Cited by 573 · see citing works

Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

Nguyen‐Tan, P. F., Zhang, Q., Ang, K. K., Weber, R. S., Rosenthal, D. I., Soulières, D., Kim, H. L., Silverman, C. I., Raben, A., Galloway, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3925 · Cited by 476 · see citing works

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Lai, A., Tran, A. N., Nghiemphu, P. L., Pope, W. B., Solis, O. E., Selch, M. T., Filka, E., Yong, W. H., Mischel, P. S., Liau, L. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2729 · Cited by 456 · see citing works

Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)

Chinnaiyan, P., Huang, S., Vallabhaneni, G. D., Armstrong, E. A., Varambally, S., Tomlins, S. A., Chinnaiyan, A. M., & Harari, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3547 · Cited by 388 · see citing works

Cancer in older persons: an international issue in an aging world

Yancik, R. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.12.024 · Cited by 364 · see citing works

Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis

Nishijima, T. F., Muss, H. B., Shachar, S. S., & Moschos, S. J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.02.006 · Cited by 293 · see citing works

Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer

Iyengar, P., Kavanagh, B. D., Wardak, Z., Smith, I., Ahn, C. W., Gerber, D. E., Dowell, J. E., Hughes, R. S., Abdulrahman, R., Camidge, D. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.7412 · Cited by 286 · see citing works

Treatment of HER2-positive breast cancer

Magalhães, M. C. F., Jelovac, D., Connolly, R. M., & Wolff, A. C. (2013) · The Breast · doi:10.1016/j.breast.2013.11.011 · Cited by 273 · see citing works

A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma

Hiniker, S. M., Reddy, S. A., Maecker, H. T., Subrahmanyam, P. B., Rosenberg‐Hasson, Y., Swetter, S. M., Saha, S., Shura, L., & Knox, S. J. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.07.005 · Cited by 233 · see citing works

Comprehensive Geriatric Oncology

(2004) · CRC Press eBooks · doi:10.3109/9780203494516 · Cited by 226 · see citing works

Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial

Magrini, S. M., Buglione, M., Corvò, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.1671 · Cited by 215 · see citing works

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Martins, R. G., Parvathaneni, U., Bauman, J. E., Sharma, A. K., Raez, L. E., Papagikos, M. A., Yunus, F., Kurland, B. F., Eaton, K. D., Liao, J. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3299 · Cited by 205 · see citing works

Immune checkpoint inhibitors and elderly people: A review

Daste, A., Domblides, C., Gross‐Goupil, M., Chakiba, C., Quivy, A., Cochin, V., de Monès, E., Larmonier, N., Soubeyran, P., & Ravaud, A. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.044 · Cited by 189 · see citing works

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer

Lartigau, E. F., Tresch, E., Thariat, J., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.012 · Cited by 186 · see citing works

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

Koller, K. M., Mackley, H. B., Liu, J., Wagner, H., Talamo, G., Schell, T. D., Pameijer, C., Neves, R. I., Anderson, B. E., Kokolus, K. M., et al. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1264543 · Cited by 157 · see citing works

A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

Vargo, J. A., Ferris, R. L., Ohr, J. P., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.11.023 · Cited by 156 · see citing works

Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck Cancer

Seiwert, T. Y., Haraf, D. J., Cohen, E. E. W., Stenson, K. M., Witt, M. E., Dekker, A., Kocherginsky, M., Weichselbaum, R. R., Chen, H. X., & Vokes, E. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1706 · Cited by 153 · see citing works

High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes

Giro, C., Berger, B., Bölke, E., et al. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.09.007 · Cited by 152 · see citing works

Chemoradiotherapy and Gefitinib in Stage III Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor and KRAS Mutation Analysis: Cancer and Leukemia Group B (CALEB) 30106, a CALGB-Stratified Phase II Trial

Ready, N., Janne, P. A., Bogart, J. A., DiPetrillo, T. A., Garst, J. L., Graziano, S. L., Gu, L., Wang, X., Green, M. R., & Vokes, E. E. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181eba657 · Cited by 145 · see citing works

A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer

Albiges, L. K., Choueiri, T. K., Escudier, B. J., Galsky, M. D., George, D., Hofmann, F., Lam, T. B. L., Motzer, R. J., Mulders, P., Porta, C., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.04.006 · Cited by 138 · see citing works

Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival

Babu, R., Komisarow, J. M., Agarwal, V. J., Rahimpour, S., Iyer, A., Britt, D., Karikari, I. O., Grossi, P. M., Thomas, S. M., Friedman, A. H., et al. (2015) · Journal of neurosurgery · doi:10.3171/2015.4.jns142200 · Cited by 133 · see citing works

Gefitinib Radiosensitizes Non–Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

Tanaka, T., Munshi, A., Brooks, C., Liu, J. X., Hobbs, M. L., & Meyn, R. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1606 · Cited by 129 · see citing works

Simultaneous anti‐angiogenic therapy and single‐fraction radiosurgery in clinically relevant metastases from renal cell carcinoma

Staehler, M. D., Haseke, N., Nuhn, P., et al. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09895.x · Cited by 124 · see citing works

Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma

Safran, H. P., DiPetrillo, T. A., Akerman, P., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.076 · Cited by 119 · see citing works

The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits

Hanna, T. P., Shafiq, J., Delaney, G. P., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.11.004 · Cited by 114 · see citing works

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

Tazi, K., Hathaway, A. R., Chiuzan, C. C., & Shirai, K. (2014) · Cancer Medicine · doi:10.1002/cam4.315 · Cited by 111 · see citing works

Nivolumab induced radiation recall pneumonitis after two years of radiotherapy

Shibaki, R., Akamatsu, H., Fujimoto, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx115 · Cited by 108 · see citing works

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Velenik, V., Ocvirk, J., Mušič, M. M., Bračko, M., Anderluh, F., Oblak, I., Edhemović, I., Brecelj, E., Kropivnik, M., & Omejc, M. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-105 · Cited by 88 · see citing works

Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases

Kao, J., Chen, C., Tong, C. C. L., Packer, S. H., Schwartz, M., Chen, S., & Sung, M. W. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0280-y · Cited by 82 · see citing works

Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial

Kennecke, H. F., Berry, S., Wong, R., Zhou, C., Tankel, K., Easaw, J. C., Rao, S. C., Post, J., & Hay, J. H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.016 · Cited by 72 · see citing works

Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer

Komaki, R. R., Allen, P. K., Wei, X., Blumenschein, G. R., Tang, X., Lee, J. J., Welsh, J. W., Wistuba, I. I., Liu, D. D., & Hong, W. K. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.02.005 · Cited by 69 · see citing works

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma

Pollom, E. L., Bui, T. T., Chang, A. L. S., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.0326 · Cited by 64 · see citing works

Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma

Miller, J. A., Balagamwala, E. H., Angelov, L., et al. (2016) · Journal of Neurosurgery Spine · doi:10.3171/2016.4.spine16229 · Cited by 64 · see citing works

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)

Michaelson, M. D., Hu, C., Pham, H., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.12.018 · Cited by 63 · see citing works

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers

Salama, J. K., Haraf, D. J., Stenson, K. M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq736 · Cited by 62 · see citing works

Optimization of Immunotherapy in Elderly Cancer Patients

Tomihara, K., Curiel, T. J., & Zhang, B. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013010591 · Cited by 58 · see citing works

A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Lilenbaum, R., Samuels, M. A., Wang, X., Kong, F., Janne, P. A., Masters, G. A., Katragadda, S., Hodgson, L. C., Bogart, J. A., Bradley, J. D., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000347 · Cited by 55 · see citing works

A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer

Willett, C. G., Duda, D. G., Ancukiewicz, M., Shah, M., Czito, B. G., Bentley, R. C., Poleski, M. H., Fujita, H., Lauwers, G. Y., Carroll, M. D., et al. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0030 · Cited by 54 · see citing works

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.

Lau, D. H., Crowley, J. J., Gandara, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3078 · Cited by 53 · see citing works

Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy

Saran, F. H., Chinot, O. L., Henriksson, R., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov300 · Cited by 51 · see citing works

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

Roviello, G., Zanotti, L., Cappelletti, M. R., et al. (2017) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0460-7 · Cited by 49 · see citing works

Targeted therapy and elderly people: A review

Daste, A., Chakiba, C., Domblides, C., Gross‐Goupil, M., Quivy, A., Ravaud, A., & Soubeyran, P. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.005 · Cited by 47 · see citing works

Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer

Staehler, M. D., Haseke, N., Stadler, T. C., et al. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.02.006 · Cited by 44 · see citing works

PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report

Nagasaka, M., Zaki, M., Kim, H., Raza, S. N., Yoo, G., Lin, H.-S., & Sukari, A. (2016) · Journal of Immunotherapy for Cancer · doi:10.1186/s40425-016-0187-0 · Cited by 43 · see citing works

Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712

Davies, A. M., Chansky, K., Lau, D. H., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0268 · Cited by 42 · see citing works

Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review

Mignot, F., Ajgal, Z. C., Xu, H., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.006 · Cited by 41 · see citing works

The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study

Wada, Y., Takami, Y., Matsushima, H., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.9826-17 · Cited by 41 · see citing works

Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy

Stokes, W. A., Binder, D. C., Jones, B. L., Oweida, A., Liu, A. K., Rusthoven, C. G., & Karam, S. D. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.10.006 · Cited by 37 · see citing works

Clinical Observation of Whole Brain Radiotherapy Concomitant with Targeted Therapy for Brain Metastasis in Non-small Cell Lung Cancer Patients with Chemotherapy Failure

Cai, Y., Wang, J., & Liu, H. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.5699 · Cited by 36 · see citing works

Pneumonitis in cancer patients receiving anti-PD-1 and radiotherapies

Lu, C., & Liu, H. (2017) · Medicine · doi:10.1097/md.0000000000005747 · Cited by 34 · see citing works

Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience

Jensen, A. D., Bergmann, Z. P., Schüler, H. I. G., et al. (2010) · Head & Neck Oncology · doi:10.1186/1758-3284-2-34 · Cited by 33 · see citing works

Treatment of Advanced Basal Cell Carcinoma with Sonidegib: Perspective from the 30-Month Update of the BOLT Trial

Chen, L. L., Aria, A. B., Silapunt, S., Lee, H., & Migden, M. R. (2017) · Future Oncology · doi:10.2217/fon-2017-0457 · Cited by 33 · see citing works

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study

Xu, Y., Zheng, Y., Sun, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5193 · Cited by 32 · see citing works

Erlotinib and Radiation Therapy for Elderly Patients with Esophageal Cancer - Clinical and Correlative Results from a Prospective Multicenter Phase 2 Trial

Iyer, R. V., Chhatrala, R., Shefter, T., Yang, G., Malhotra, U., Tan, W., LeVea, C., Robins, M., & Khushalani, N. I. (2013) · Oncology · doi:10.1159/000351617 · Cited by 30 · see citing works

Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrence

Yoshida, T., Furuta, H., & Hida, T. (2017) · Medical Oncology · doi:10.1007/s12032-017-0895-4 · Cited by 28 · see citing works

Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck

Schulze, B., Meißner, M., Ghanaati, S., et al. (2015) · Strahlentherapie und Onkologie · doi:10.1007/s00066-015-0902-7 · Cited by 27 · see citing works

Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis

Zheng, M.-H., Sun, H., Xu, J.-G., et al. (2016) · BioMed Research International · doi:10.1155/2016/5807346 · Cited by 26 · see citing works

Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer

Boyer, M. J., Gu, L., Wang, X., Kelsey, C. R., Yoo, D. S., Onaitis, M. W., Dunphy, F., Crawford, J., Ready, N., & Salama, J. K. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.014 · Cited by 26 · see citing works

Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature

Manapov, F., Roengvoraphoj, O., Dantes, M., et al. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000198 · Cited by 26 · see citing works

Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study

Zhai, Y., Hui, Z., Wang, J., et al. (2012) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2012.01380.x · Cited by 23 · see citing works

Effects of an Epithelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Add-on in Stereotactic Radiosurgery for Brain Metastases Originating from Non-Small-Cell Lung Cancer

Kim, H. J., Kim, W. S., Kwon, D. H., et al. (2015) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2015.58.3.205 · Cited by 23 · see citing works

Trastuzumab and Hypofractionated Whole Breast Radiotherapy: A Victorious Combination?

Santis, M. C. D., Bonfantini, F., Salvo, F. D., et al. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.08.011 · Cited by 22 · see citing works

Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data

Maroun, R., Mitrofan, L. M., Benjamin, L., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4117-z · Cited by 22 · see citing works

Feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a Phase II trial

Martinez, E. C., Rico, M., Martínez, M., et al. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s89755 · Cited by 21 · see citing works

The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.

Glynne‐Jones, R., Hadaki, M., & Harrison, M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2013.037 · Cited by 20 · see citing works

Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: Our experience and review of the literature

Kusuda, Y., Miyake, H., Terakawa, T., et al. (2011) · International Journal of Urology · doi:10.1111/j.1442-2042.2010.02706.x · Cited by 18 · see citing works

Radiotherapy for elderly patients and cetuximab, a monocentric study

Falk, A. T., Hébert, C., Tran, A., et al. (2016) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-016-4336-3 · Cited by 17 · see citing works

Compassionate use of vismodegib and adjuvant radiotherapy in the treatment of multiple locally advanced and inoperable basal cell carcinomas and squamous cell carcinomas of the skin

Gathings, R. M., Orscheln, C. S., & Huang, W. W.-T. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.032 · Cited by 16 · see citing works

Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma

Yao, M., Woods, C., Lavertu, P., et al. (2016) · Head & Neck · doi:10.1002/hed.24313 · Cited by 16 · see citing works

Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis

Song, T., Du, D., Zhang, X., et al. (2017) · Diseases of the Esophagus · doi:10.1093/dote/dox060 · Cited by 15 · see citing works

Clinical study on gefitinib combined with γ-ray stereotactic body radiation therapy as the first-line treatment regimen for senile patients with adenocarcinoma of the lung (final results of JLY20080085)

Pan, D., Wang, B., Zhou, X., et al. (2013) · Molecular and Clinical Oncology · doi:10.3892/mco.2013.135 · Cited by 7 · see citing works

Locoregionally advanced squamous cell carcinoma of the head and neck: chemoradiation or bioradiation

Specenier, P. M., & Vermorken, J. B. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.06.29 · Cited by 6 · see citing works

Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer

Fiore, M., Angelillo, R. M. D. A., Greco, C., et al. (2018) · Chemotherapy · doi:10.1159/000488252 · Cited by 6 · see citing works

Immunosenescence: a key player in cancer development

Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00986-z · Cited by 510 · see citing works

STUDY ON THE EFFECTS OF RADIOTHERAPY ON T-CELL SUBGROUPS OF THE MALIGNANT TUMOR PATIENTS

Zhao, H. (2000) · Journal of Nantong Medical

Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer

Bouche, G., Ingrand, I., Mathoulin‐Pélissier, S., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.011 · Cited by 19 · see citing works

Radiotherapy

Dunleavey, R. (2008) · Cervical cancer · doi:10.1002/9780470988046.ch4

Comparison of the effects between three different therapy methods for non-small cell lung cancer.

Li, X. (2002) · Yunnan yiyao

Clinical efficacy of chemo radiotherapy and single radiotherapy treatment on advanced cervical cancer

Ye, Y.-F. (2012) · Hainan Yixueyuan xuebao